NPS Pharmaceuticals, Inc. (NPSP: Quote) announced that the U.S. Food and Drug Administration, or FDA, has posted briefing materials for the October 16, 2012 Gastrointestinal Drugs Advisory Committee meeting to review Gattex (teduglutide).
Gattex is a new, recombinant analog of human glucagon-like peptide 2 (a protein involved in the rehabilitation of the intestinal lining) being developed for the treatment of adults with short bowel syndrome.
Click here to receive FREE breaking news email alerts for NPS Pharmaceuticals Inc and others in your portfolio
by RTT Staff Writer
For comments and feedback: email@example.com